Marc Dunoyer


Marc became chief executive officer of Alexion, AstraZeneca’s Rare Disease group, in August 2021 following its acquisition in July. Marc previously served as executive director and chief financial officer of AstraZeneca since November 2013. Marc’s career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel, a...

Roles at Orchard Therapeutics PLC

  • Director

    Current role

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at Orchard Therapeutics PLC

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.